(Q35151575)

6 August 2017

1 reference

title

Changes in the perceived epidemiology of primary hyperaldosteronism (English)

1 reference

6 August 2017

1 reference

Riccardo Maria Fagugli

series ordinal

1

1 reference

6 August 2017

Chiara Taglioni

series ordinal

2

1 reference

6 August 2017

publication date

4 August 2011

1 reference

International Journal of Hypertension

6 August 2017

published in

1 reference

6 August 2017

volume

2011

1 reference

6 August 2017

page(s)

162804

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Adrenocortical causes of hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Aldosteronism and hypertension

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Primary aldosteronism--actual epidemics or false alarm?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Mineralocorticoids and cardiac fibrosis: the decade in review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Commentary on incidence of primary aldosteronism: current estimations based on objective data

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

13 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Low-renin status in therapy-resistant hypertension: a clue to efficient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor bl

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Primary aldosteronism in diabetic subjects with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Primary aldosteronism and hypertensive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Cardiovascular outcomes in patients with primary aldosteronism after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3151507

Is there an unrecognized epidemic of primary aldosteronism? Con

25 October 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F162804

The evolution of primary aldosteronism: 1954-1967

21 January 2018

1 reference

12 December 2020

Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology

1 reference

12 December 2020

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

12 December 2020

High incidence of primary aldosteronism in 199 patients referred with hypertension

1 reference

12 December 2020

Identifiers

DOI

10.4061/2011/162804

1 reference

6 August 2017

1 reference

6 August 2017

1 reference